Riverbridge Partners LLC Buys 181,277 Shares of Option Care Health, Inc. $OPCH

Riverbridge Partners LLC grew its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 14.3% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,446,956 shares of the company’s stock after purchasing an additional 181,277 shares during the period. Riverbridge Partners LLC owned approximately 0.89% of Option Care Health worth $40,168,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of OPCH. Durable Capital Partners LP lifted its holdings in Option Care Health by 134.2% in the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock worth $267,557,000 after buying an additional 4,720,988 shares during the period. Norges Bank purchased a new position in shares of Option Care Health in the 2nd quarter valued at approximately $69,932,000. Arrowstreet Capital Limited Partnership lifted its stake in shares of Option Care Health by 109.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 3,410,394 shares of the company’s stock valued at $110,770,000 after purchasing an additional 1,778,279 shares during the period. Jennison Associates LLC boosted its position in shares of Option Care Health by 145.6% during the second quarter. Jennison Associates LLC now owns 2,138,248 shares of the company’s stock valued at $69,450,000 after purchasing an additional 1,267,660 shares in the last quarter. Finally, Duquesne Family Office LLC purchased a new stake in Option Care Health in the second quarter worth $20,685,000. 98.05% of the stock is owned by institutional investors.

Option Care Health Stock Up 0.3%

Shares of Option Care Health stock opened at $32.51 on Monday. The company has a 50-day simple moving average of $29.32 and a two-hundred day simple moving average of $29.35. The stock has a market capitalization of $5.16 billion, a PE ratio of 25.80, a price-to-earnings-growth ratio of 2.19 and a beta of 0.80. Option Care Health, Inc. has a 52-week low of $22.45 and a 52-week high of $35.53. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.05 and a current ratio of 1.56.

Insiders Place Their Bets

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 38,000 shares of the stock in a transaction that occurred on Monday, November 3rd. The shares were acquired at an average cost of $25.98 per share, with a total value of $987,240.00. Following the transaction, the director owned 413,390 shares of the company’s stock, valued at $10,739,872.20. The trade was a 10.12% increase in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.64% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of brokerages have recently commented on OPCH. Wall Street Zen cut shares of Option Care Health from a “buy” rating to a “hold” rating in a report on Sunday, December 14th. Cowen initiated coverage on shares of Option Care Health in a research note on Thursday, October 2nd. They set a “hold” rating on the stock. Weiss Ratings restated a “hold (c)” rating on shares of Option Care Health in a report on Monday, December 15th. Morgan Stanley initiated coverage on shares of Option Care Health in a report on Friday, October 17th. They set an “overweight” rating and a $35.00 target price for the company. Finally, JMP Securities set a $36.00 price target on Option Care Health in a research report on Friday, October 31st. One research analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $36.27.

About Option Care Health

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.